Caplin

Caplin Point Laboratories is a prominent Indian pharmaceutical company specializing in the development and manufacture of generic formulations across diverse therapeutic areas. The company maintains a dominant market position in Latin America and Francophone Africa through a unique end-to-end business model that integrates manufacturing with direct distribution. Its subsidiary, Caplin Steriles, focuses on the high-growth regulated markets of the United States and Europe, producing complex injectables and ophthalmic products. Caplin Point's portfolio includes a wide array of dosage forms such as tablets, capsules, liquid orals, and sterile products. The company is recognized for its robust R&D capabilities and state-of-the-art manufacturing facilities that comply with international regulatory standards like the US FDA and EU GMP.